BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18602827)

  • 1. Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A.
    Chung KW; Suh BC; Shy ME; Cho SY; Yoo JH; Park SW; Moon H; Park KD; Choi KG; Kim S; Kim SB; Shim DS; Kim SM; Sunwoo IN; Choi BO
    Neuromuscul Disord; 2008 Aug; 18(8):610-8. PubMed ID: 18602827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A.
    Vinci P; Serrao M; Pierelli F; Sandrini G; Santilli V
    Funct Neurol; 2006; 21(3):159-63. PubMed ID: 17049135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)].
    Sobue G
    Rinsho Shinkeigaku; 2003 Nov; 43(11):769-74. PubMed ID: 15152460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.
    Sivera R; Espinós C; Vílchez JJ; Mas F; Martínez-Rubio D; Chumillas MJ; Mayordomo F; Muelas N; Bataller L; Palau F; Sevilla T
    J Peripher Nerv Syst; 2010 Dec; 15(4):334-44. PubMed ID: 21199105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hand involvement in children with Charcot-Marie-Tooth disease type 1A.
    Burns J; Bray P; Cross LA; North KN; Ryan MM; Ouvrier RA
    Neuromuscul Disord; 2008 Dec; 18(12):970-3. PubMed ID: 18993073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
    Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
    JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A family of early childhood-onset Charcot-Marie-Tooth disease type 2].
    Hinuma Y; Aoki M; Takahashi T; Tateyama M; Nagai M; Yoshioka M; Itoyama Y
    Rinsho Shinkeigaku; 2001 Jan; 41(1):64-7. PubMed ID: 11433771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of muscle atrophy in the lower limbs in patients with Charcot-Marie-Tooth disease as measured by magnetic resonance imaging.
    Stilwell G; Kilcoyne RF; Sherman JL
    J Foot Ankle Surg; 1995; 34(6):583-6; discussion 596. PubMed ID: 8646212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study.
    Berciano J; Gallardo E; García A; Infante J; Mateo I; Combarros O
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1169-76. PubMed ID: 16788010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
    Roa BB; Garcia CA; Lupski JR
    Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children.
    Desurkar A; Lin JP; Mills K; Al-Sarraj S; Jan W; Jungbluth H; Wraige E
    Neuropediatrics; 2009 Apr; 40(2):85-8. PubMed ID: 19809938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic heterogeneity in Japanese Charcot-Marie-Tooth disease type 1A patients with PMP-22 gene duplication].
    Yamamoto M; Sobue G; Yasuda T; Yamamoto K; Kumazawa K; Mitsuma T
    Rinsho Shinkeigaku; 1995 Oct; 35(10):1085-91. PubMed ID: 8821490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Charcot-Marie-Tooth disease].
    Lee YC; Chang MH; Lin KP
    Acta Neurol Taiwan; 2008 Sep; 17(3):203-13. PubMed ID: 18975529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication.
    Berciano J; García A; Combarros O
    Muscle Nerve; 2003 Jan; 27(1):34-9. PubMed ID: 12508292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study.
    Teunissen LL; Notermans NC; Franssen H; Van Engelen BG; Baas F; Wokke JH
    Arch Neurol; 2003 Jun; 60(6):823-8. PubMed ID: 12810486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large family with Charcot-Marie-Tooth Type 1a and Type 2 diabetes mellitus.
    Koç F; Sarica Y; Yerdelen D; Baris I; Battaloglu E; Sert M
    Int J Neurosci; 2006 Feb; 116(2):103-14. PubMed ID: 16393877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Marie-Tooth disease type 1A: clinicopathological correlations in 24 patients.
    Carvalho AA; Vital A; Ferrer X; Latour P; Lagueny A; Brechenmacher C; Vital C
    J Peripher Nerv Syst; 2005 Mar; 10(1):85-92. PubMed ID: 15703022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.